Abstract：Objective: To compare the results of superselective prostate artery embolization (PAE) and transurethral plasma bipolar prostatectomy (TUPKP) for giant benign prostatic hyperplasia (BPH).Methods: A retrospective analysis was made on 144 patients with BPH whose prostate volume was more than 80 cm3 from October 2016 to August 2017. Among them, 42 patients underwent PAE and 102 patients underwent TUPKP. Relevant observation indexes before and after operation, as well as complication rates were analyzed and compared. RESULTS: Compared with the preoperative data, Qmax in PAE group and TUPKP group was significantly increased at 3rd, 6th and 12th month after surgery (P<0.05), and PSA, PV, IPSS, QOL and PVR all decreased significantly (P<0.05); The evaluation indexes of TUPKP group were significantly better than those of PAE group at 3rd month after surgery (P<0.05). PV and PSA in PAE group were significantly higher than those in TUPKP group at 6th and 12th month after surgery (P<0.05); There was no significant difference between the two groups in IPSS, QOL, Qmax and PVR at 6th and 12th month after surgery (P>0.05). Three cases (2.9%) in TUPKP group were found to have prostate cancer by pathological examination after operation, including 1 case of T1a stage, and 2 cases of T1b stage. There was no clinical evidence of prostate cancer in PAE group during the follow-up period. The operation time and hospital stay in PAE group were significantly shorter than those in TUPKP group (P<0.05). There was no significant difference in indwelling time between two groups (P>0.05). The NRS value in PAE group was significantly lower than that in TUPKP group (P<0.05). The incidence of postoperative complications in TUPKP group was significantly higher than that in PAE group (P<0.05). Conclusion: After effectively preoperative screening, PAE can be used as an effective alternative treatment for giant BPH.
王文祥, 李雷, 李海, 李杨, 侯毅. 两种术式治疗较大体积良性前列腺增生的临床比较[J]. 微创泌尿外科杂志, 2019, 8(3): 200-204.
WANG Wenxiang, LI Lei, LI Hai, LI Yang, HOU Yi. Prostate artery embolization vs. transurethral bipolar plasmakinetic prostatectomy in the treatment of large benign prostatic hyperplasia. JOURNAL OF MINIMALLY INVASIVE UROLOGY, 2019, 8(3): 200-204.
[1] MCVARY KT, ROEHRBORN CG, AVINS AL, et al.Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol, 2011,185(5):1793-1803. [2] SALEM R, HAIRSTON J, HOHLASTOS E, et al.Prostate artery embolization for lower urinary tract symptoms secondary to benign prostatic hyperplasia: results from a prospective FDA-approved investigational device exemption study. Urology, 2018,120:205-210. [3] 邱志磊,王荃,程楷,等.超选择性前列腺动脉栓塞术治疗前列腺增生的临床评价.中华泌尿外科杂志,2016,37(10):758-761. [4] CARNEVALE FC, ANTUNES AA,DA MOTTA LEAL FILHO JM , et al.Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Intervent Radiol, 2010,33(2):355-361. [5] CARNEVALE FC,DA MOTTA LEAL FILHO JM, ANTUNES AA, et al.Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia. J Vasc Interv Radiol, 2013,24(4):535-542. [6] AUA PRACTICE GUIDELINES COMMITTEE. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol, 2003,170(2 Pt 1):530-547. [7] 熊文清,万建,付明.经尿道前列腺等离子双极电切术治疗大体积良性前列腺增生症疗效观察.临床外科杂志,2015,23(10):789-791. [8] DEMERITT JS, ELMASRI FF, ESPOSITO MP, et al.Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization. J Vasc Interv Radiol, 2000,11(6):767-770. [9] PISCO J, CAMPOS PINHEIRO L, BILHIM T, et al.Prostatic arterial embolization for benign prostatic hyperplasia: short-and intermediate-term results. Radiology, 2013,266(2):668-677. [10] 袁冰,王茂强,张国栋,等.超选择性前列腺动脉栓塞术治疗巨大前列腺增生所致下尿路阻塞的价值.中华放射学杂志,2018,52(3):223-227. [11] CARNEVALE FC, ISCAIFE A, YOSHINAGA EM, et al.Transurethral resection of the prostate (TURP) versus original and PErFecTED prostate artery embolization (PAE) due to benign prostatic hyperplasia (BPH): preliminary results of a single center, prospective, urodynamic-controlled analysis. Cardiovasc Intervent Radiol, 2016,39(1):44-52. [12] DE ASSIS AM, MOREIRA AM, DE PAULA RODRIGUES VC, et al.Prostatic artery embolization for treatment of benign prostatic hyperplasia in patients with prostates > 90 g: a prospective single-center study. J Vasc Interv Radiol, 2015,26(1):87-93. [13] BILHIM T, PISCO JM, FURTADO A, et al.Prostatic arterial supply: demonstration by multirow detector angio CT and catheter angiography. Eur Radiol, 2011,21(5):1119-1126. [14] 高元安,张瑞,冯宝安,等.动脉栓塞治疗前列腺增生12例.中华放射学杂志,2006,40(12):1314-1316. [15] 常钢,陈志强,杨志刚,等.前列腺动脉造影表现及方法探讨.介入放射学杂志,2004,13(1):28-30. [16] BILHIM T, PISCO JM, RIO TINTO H, et al.Prostatic arterial supply: anatomic and imaging findings relevant for selective arterial embolization. J Vasc Interv Radiol, 2012,23(11):1403-1415. [17] 朱伟,方主亭,朱庆国,等.超选择性前列腺动脉栓塞术治疗高危良性前列腺增生48例报告.中华泌尿外科杂志,2015,36(12):949-951. [18] 关喜彬,武良,舒则荣,等.经尿道前列腺等离子双极电切术安全性与有效性的系统评价.浙江创伤外科,2015,20(4):641-644. [19] SUN F, SÁNCHEZ FM, CRISÓSTOMO V, et al. Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment--preliminary study in pigs. Radiology, 2008,246(3):783-789. [20] 王刚,周利群,那彦群.良性前列腺增生术后前列腺偶发癌10年回顾性分析.中华泌尿外科杂志,2005,26(2):117-120. [21] LABORDA A, ASSIS AD, IOAKEIM I, et al.Radiodermitis after prostatic artery embolization:case report and review of the literature. Cardiovasc Intervent Radiol, 2015,38(3):755-759. [22] 赵林,马永宏,陈其,等.铲状电极经尿道前列腺等离子剜除术与等离子切除术治疗BPH的临床比较.中华男科学杂志,2018,24(2):133-137. [23] 胡骏,劳丽娟,平秦榕,等.经尿道双极等离子电切术治疗良性前列腺增生症.国际泌尿系统杂志,2017,37(2):210-213.
